Vector Biosource Acquisition to Boost FOXO Growth FOXO Technologies announced plans to acquire Vector Biosource, a biospecimen provider, for $750,000 in Series D Preferred Stock, with further payments tied to revenue milestones. This move aims to strengthen FOXO’s biotechnology offerings and expand its platform aggressively. The closing depends on due diligence and additional conditions.456